1. Home
  2. BEEM vs KYNB Comparison

BEEM vs KYNB Comparison

Compare BEEM & KYNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Beam Global

BEEM

Beam Global

BUY

Current Price

$0.91

Market Cap

28.6M

Sector

Technology

ML Signal

BUY

Logo Kyntra Bio Inc. Common Stock

KYNB

Kyntra Bio Inc. Common Stock

BUY

Current Price

$5.22

Market Cap

32.8M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
BEEM
KYNB
Founded
2006
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
28.6M
32.8M
IPO Year
2018
2014

Fundamental Metrics

Financial Performance
Metric
BEEM
KYNB
Price
$0.91
$5.22
Analyst Decision
Buy
Buy
Analyst Count
3
5
Target Price
$2.50
★ $38.50
AVG Volume (30 Days)
★ 578.4K
22.5K
Earning Date
11-13-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
40.77
★ 9552.08
EPS
N/A
★ N/A
Revenue
★ $28,236,000.00
$6,440,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$37.39
$14.12
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.82
$4.85
52 Week High
$3.09
$9.66

Technical Indicators

Market Signals
Indicator
BEEM
KYNB
Relative Strength Index (RSI) 24.74 29.52
Support Level N/A N/A
Resistance Level $1.66 $7.41
Average True Range (ATR) 0.06 0.37
MACD -0.02 -0.07
Stochastic Oscillator 24.97 17.37

Price Performance

Historical Comparison
BEEM
KYNB

About BEEM Beam Global

Beam Global is a clean-technology innovation company. It develop, design, engineer, manufacture, and sell high-quality, renewably energized infrastructure products for electric vehicle ( EV ) charging, infrastructure for Smart Cities (the interconnected physical and digital elements within a city that utilize technology to enhance efficiency, sustainability, and quality of life for residents), energy security and disaster preparedness and energy-dense battery solutions in safe, compact and form-factors. Additionally, the company manufactures structures with electronic integration such as streetlighting, cell towers and energy infrastructure products as well as power electronics including invertors, charge controllers, power supplies and LED lighting.

About KYNB Kyntra Bio Inc. Common Stock

Kyntra Bio Inc is a biopharmaceutical company focused on the development of novel therapies in oncology and rare disease. The company's research programs target cancer and rare disease indications, including anemia associated with lower-risk myelodysplastic syndrome (LR-MDS) and metastatic castration-resistant prostate cancer (mCRPC). Itd pipeline drug candidates include Roxadustat and FG-3246.

Share on Social Networks: